| Product Code: ETC8618313 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Despite a decline in the growth rate of antivirals imports to Nigeria in 2024, the market remains concentrated with top exporters like India, China, and the USA leading the way. The high concentration measured by the Herfindahl-Hirschman Index (HHI) indicates a competitive market dominated by a few key players. The negative Compound Annual Growth Rate (CAGR) over the period of 2020-2024 suggests a challenging environment, while the further decline in growth rate from 2023 to 2024 highlights potential shifts in market dynamics. Nigeria`s reliance on these top exporting countries underscores the importance of monitoring global trends in the pharmaceutical industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Nigeria Antivirals Market Overview |
3.1 Nigeria Country Macro Economic Indicators |
3.2 Nigeria Antivirals Market Revenues & Volume, 2021 & 2031F |
3.3 Nigeria Antivirals Market - Industry Life Cycle |
3.4 Nigeria Antivirals Market - Porter's Five Forces |
3.5 Nigeria Antivirals Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Nigeria Antivirals Market Revenues & Volume Share, By Actions, 2021 & 2031F |
4 Nigeria Antivirals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases and viral outbreaks in Nigeria |
4.2.2 Growing awareness among the population about the importance of antiviral treatments |
4.2.3 Government initiatives and funding to improve healthcare infrastructure and access to antivirals |
4.3 Market Restraints |
4.3.1 High cost of antiviral drugs limiting affordability for a large segment of the population |
4.3.2 Lack of skilled healthcare professionals and infrastructure in remote areas impacting distribution and access to antivirals |
5 Nigeria Antivirals Market Trends |
6 Nigeria Antivirals Market, By Types |
6.1 Nigeria Antivirals Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Nigeria Antivirals Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Nigeria Antivirals Market Revenues & Volume, By Hepatitis-C antivirals, 2021- 2031F |
6.1.4 Nigeria Antivirals Market Revenues & Volume, By HIV antivirals, 2021- 2031F |
6.1.5 Nigeria Antivirals Market Revenues & Volume, By Herpes antivirals, 2021- 2031F |
6.1.6 Nigeria Antivirals Market Revenues & Volume, By Hepatitis-B antivirals, 2021- 2031F |
6.1.7 Nigeria Antivirals Market Revenues & Volume, By Influenza antivirals, 2021- 2031F |
6.1.8 Nigeria Antivirals Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Nigeria Antivirals Market, By Actions |
6.2.1 Overview and Analysis |
6.2.2 Nigeria Antivirals Market Revenues & Volume, By DNA polymerase inhibitors, 2021- 2031F |
6.2.3 Nigeria Antivirals Market Revenues & Volume, By NS3 Protease inhibitors, 2021- 2031F |
6.2.4 Nigeria Antivirals Market Revenues & Volume, By Reverse transcriptase inhibitors, 2021- 2031F |
6.2.5 Nigeria Antivirals Market Revenues & Volume, By Others, 2021- 2031F |
7 Nigeria Antivirals Market Import-Export Trade Statistics |
7.1 Nigeria Antivirals Market Export to Major Countries |
7.2 Nigeria Antivirals Market Imports from Major Countries |
8 Nigeria Antivirals Market Key Performance Indicators |
8.1 Number of antiviral prescriptions filled |
8.2 Rate of adoption of new antiviral treatments in the market |
8.3 Patient adherence rate to prescribed antiviral therapies |
9 Nigeria Antivirals Market - Opportunity Assessment |
9.1 Nigeria Antivirals Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Nigeria Antivirals Market Opportunity Assessment, By Actions, 2021 & 2031F |
10 Nigeria Antivirals Market - Competitive Landscape |
10.1 Nigeria Antivirals Market Revenue Share, By Companies, 2024 |
10.2 Nigeria Antivirals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |